{"transactions":[{"id":329,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:03:52.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001441889-26-000002","document":"wk-form4_1788379430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000144188926000002/wk-form4_1788379430.xml","form_type":"4"}},{"id":716081,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T13:26:20.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":9633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split."}],"balance_after":23892,"source":{"system":"sec-edgar","filing":"0001628280-26-047126","document":"wk-form4_1783344377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026047126/wk-form4_1783344377.xml","form_type":"4"}},{"id":1139330,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T23:07:20.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 20, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":142597,"source":{"system":"sec-edgar","filing":"0001104659-25-051713","document":"tm2515860-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925051713/tm2515860-5_4seq1.xml","form_type":"4"}},{"id":1140344,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T20:07:35.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000089","document":"wk-form4_1747771647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148525000089/wk-form4_1747771647.xml","form_type":"4"}},{"id":1352595,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T12:32:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000089","document":"wk-form4_1732537934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148524000089/wk-form4_1732537934.xml","form_type":"4"}},{"id":1504150,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T23:02:35.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":36111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":92597,"source":{"system":"sec-edgar","filing":"0001104659-24-064810","document":"tm2415466-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465924064810/tm2415466-1_4seq1.xml","form_type":"4"}},{"id":1697876,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T22:05:51.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000114036123060239/form4.xml","form_type":"4"}},{"id":1878526,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T20:18:11.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":24715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":124203,"source":{"system":"sec-edgar","filing":"0001104659-23-064638","document":"tm2316982-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465923064638/tm2316982-3_4seq1.xml","form_type":"4"}},{"id":2234064,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:26:52.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.73,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001601485-22-000052","document":"wf-form4_165515558808558.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000160148522000052/wf-form4_165515558808558.xml","form_type":"4"}},{"id":2238094,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:30:28.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":99488,"source":{"system":"sec-edgar","filing":"0001104659-22-069681","document":"tm2218111-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465922069681/tm2218111-1_4seq1.xml","form_type":"4"}},{"id":2259908,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T23:48:38.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":2037,"price":1.18,"value":2403.66,"ownership":{"direct":true},"balance_after":9383,"source":{"system":"sec-edgar","filing":"0001628280-22-015238","document":"wf-form4_165334970201347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000162828022015238/wf-form4_165334970201347.xml","form_type":"4"}},{"id":2259907,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T23:48:38.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":7346,"price":1.16,"value":8521.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7346,"source":{"system":"sec-edgar","filing":"0001628280-22-015238","document":"wf-form4_165334970201347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000162828022015238/wf-form4_165334970201347.xml","form_type":"4"}},{"id":2659398,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:24:21.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":72857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":72857,"derivative":{"exercise_price":0.9,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":72857},"source":{"system":"sec-edgar","filing":"0001628280-21-012667","document":"wf-form4_162439703839034.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012667/wf-form4_162439703839034.xml","form_type":"4"}},{"id":2659397,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T21:24:21.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,488 shares of common stock underlying unvested restricted stock units that vest on December 11, 2021, subject to the Reporting Person's continued service to the issuer."}],"balance_after":74488,"source":{"system":"sec-edgar","filing":"0001628280-21-012667","document":"wf-form4_162439703839034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012667/wf-form4_162439703839034.xml","form_type":"4"}},{"id":2796794,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:08:46.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.01,"expiration_date":"2031-03-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-21-005970","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441889/000156761921005970/doc1.xml","form_type":"4"}},{"id":2944978,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T21:30:23.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":1488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":24488,"source":{"system":"sec-edgar","filing":"0001628280-20-017529","document":"wf-form4_160806780280961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020017529/wf-form4_160806780280961.xml","form_type":"4"}},{"id":3112184,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:17:40.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":34639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest on June 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":34639,"derivative":{"exercise_price":2.04,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":34639},"source":{"system":"sec-edgar","filing":"0001628280-20-009344","document":"wf-form4_159199304249282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020009344/wf-form4_159199304249282.xml","form_type":"4"}},{"id":3112183,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":312,"kind":"person","name":"Nissenson Allen","position":1,"cik":"0001441889","reported_name":"Nissenson Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:17:40.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 11, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001628280-20-009344","document":"wf-form4_159199304249282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020009344/wf-form4_159199304249282.xml","form_type":"4"}}]}